Dihydrogen Di-?-chlorotetrakis(di-tert-butylphosphinito)dipalladate, 98%, 100mg

4-Amino-6-methyl-2H-pyridazin-3-one, 95.0%, 100mg

N-4-Boc-2-Piperazinecarboxylic acid methyl ester, 95.0%, 10g

6-(Methoxycarbonyl)nicotinic acid, 97.0%, 25g

2-Chloro-4-fluoro-3-methylpyridine, 97%, 500mg

4-Chloro-2,5-dimethylaniline, 98.0%, 5g

N-Methoxydiacetamide [Selective Acetylating Reagent]>95.0%(GC)5g

9-methyl-1-oxa-9-azaspiro[5.5]undecan-4-amine dihydrochloride, 95.0%, 250mg

5-(3-(2,5-Dichloro-4,6-dimethylpyridin-3-yl)-1,2,4-oxadiazol-5-yl)-3-nitrobenzene-1,2-diol, 98%, 100mg

Incubadora Heratherm Protocol series Advanced Protocol con ventilador de circulación, 178 l, IMH180, 1 pieza

5,5,8,8-Tetramethyl-2,3,5,6,7,8-hexahydro-1H-cyclopenta[b]naphthalen-1-one, 97.0%, 250mg

3-Chloro-4-methylbenzoic acid, 98.0%, 25g

3-(2-Amino-ethyl)-aniline, 97.0%, 500mg